CLC Number:
- R473.73
| [1] 石远凯,孙燕,于金明,等. 中国晚期原发性肺癌诊治专家共识(2016年版)[J].中国肺癌杂志,2016,19(1):1-15.DOI:10.3779/j.issn.1009-3419.2016.01.01. [2] 赫捷. 中国胸外科的现状和未来发展[J].中华医学信息导报,2015,30(22):12. [3] Massarelli E, Papadimitrakopoulou V, Welsh J, et al.Immunotherapy in Lung Cancer[J]. Transl Lung Cancer Res,2014,3(1):53-63. [4] 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)免疫检查点抑制剂相关的毒性管理指南[M].北京:人民卫生出版社,2019:17-23. [5] Sibaud V.Dermatologic Reactions to Immune Checkpoint Inhibitors: Skin Toxicities and Immunotherapy[J]. AmJClin Dermatol, 2018, 19(3):345-361. DOI: 10.1007/s40257-017-0336-3. [6] Haanen J, Carbonnel F, Robert C, et al. Management of Toxicities from Immunotherapy:Esmo Clinical Practice Guidelines for Diagnosis,Treatment and Follow-up[J]. Annals of Oncology:Official Journal of the European Society for Medical Oncology,2017,28(suppl_4):iv119-iv142. [7] 张婷婷,张丽燕,国仁秀.PD-1抑制剂治疗消化道肿瘤中免疫相关不良事件的护理[J].肿瘤综合治疗电子杂志,2019,5(1):111-114.DOI:10.12151/JMCM.2019.01-13. [8] 王艳,何瑞仙,翟敏峰,等. 程序性死亡蛋白1抑制剂引起免疫相关性皮肤毒性的护理[J].中华现代护理志,2020,26(25):3526-3529.DOI:10.3760/cma.j.cn115682-10191227-04801. [9] Gettinger S,Horn L,Jackman D,et al.Five-year Follow-up of Nivolumab in Previously Treated Advanced Non-small-cell Lung Cancer: Results From the CA209-003 Study[J].J Clin Oncol,2018,36(17):1675-1684. [10] Angell TE, Min L, Wieczorek TJ, et al.Unique Cytologic Features of Thyroiditis Caused by Immune Checkpoint Inhibitor Therapy for Malignant Melanoma[J]. Genes Diseases, 2017,5(1):46-48. [11] Maekura T, Naito M, Tahara M, et al.Predictive Factors of Niv-olumab-induced Hypothyroidism in Patients with Non-Small Cell Lung Cancer[J].In Vivo,2017,31(5):1035-1039. [12] 何瑞仙,王艳,苏伟才,等.铂类化疗药物治疗肺癌患者症状簇的调查研究[J].中国肿瘤临床与康复,2019,26(1):9-13. DOI:10.13455/j.cnki.cjcor.2019.01.03. [13] 斯晓燕,何春霞,张丽,等.免疫检查点抑制剂相关皮肤不良反应诊治建议[J].中国肺癌杂志,2019,22(10):639-644. DOI:10.3779/j.issn.1009-3419.2019.10.06. [14] Naidoo J, Wang X, Woo KM, et al.Pneumonitis In Patients Treated with Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy[J].J Clin Ooncol,2017,35(7):709-717. [15] 薛静,张丽燕.消化道肿瘤患者免疫检查点抑制剂治疗所致不良反应的护理[J].护理学报,2019,26(13):63-65. DOI:10.16460/j.issn1008-9969.2019.13.063. [16] 付恩锋,王艳,王洁.70例非小细胞肺癌患者免疫检查点抑制剂不良反应分析及护理对策[J].护理学报,2020,27(14):68-70. DOI:10.16460/j.issn1008-9969.2020.14.068. [17] Champiat S, Lambotte O, Barreau E, et al.Management of Immune Checkpoint Blockade Dysimmune Toxicities:A Collaborative Position Paper[J].Ann Oncol,2016,27(4):559-574. |
| [1] | . [J]. Journal of Nursing, 2021, 28(10): 77-78. |
| [2] | . [J]. Journal of Nursing, 2021, 28(9): 62-65. |
| [3] | LU Ting, YING Yan-ping, XU Yi, YUAN Li-xiu, ZHOU Qiong, HUANG Biao-jin. A Comparative Study of Handgrip Strength and NRS2002 in Nutritional Risk Screening of Patients with Malignant Tumors [J]. Journal of Nursing, 2021, 28(9): 1-4. |
| [4] | XIA Chao, DUAN Pei-bei, YANG Ling, YANG Li-ping, HAN Si-xuan, WANG A-qin. Symptom Clusters and Sentinel Symptoms of Gastric Cancer Patients Undergoing Postoperative Chemotherapy [J]. Journal of Nursing, 2021, 28(8): 44-49. |
| [5] | TIAN Li, LI Meng-yuan, XIAO Shu-qing, YAN Ling. Prevalence and Influence Factors of Anticipatory Grief in Advanced Cancer Patients [J]. Journal of Nursing, 2021, 28(7): 11-14. |
| [6] | . [J]. Journal of Nursing, 2021, 28(5): 12-15. |
| [7] | . [J]. Journal of Nursing, 2021, 28(5): 16-20. |
| [8] | CONG Wei-lian, ZHOU Chun-lan, HU Ming-yu, LIU Li-ping. Effect of Delayed Autologous Breast Reconstruction on Patients with Upper Extremity Lymphedema: A systematic Review [J]. Journal of Nursing, 2021, 28(4): 26-30. |
| [9] | . [J]. Journal of Nursing, 2021, 28(4): 62-66. |
| [10] | . [J]. Journal of Nursing, 2021, 28(2): 65-68. |
| [11] | JIANG Li-ling, ZHAN Meng-mei, HUANG Qiu-xia, LI Li-qun, ZHANG Shu, Gong Jing-jing, WANG Jian-ning. Sexual Experience of Breast Cancer Patients: A Qualitative Meta-synthesis [J]. Journal of Nursing, 2021, 28(1): 33-37. |
| [12] | . [J]. Journal of Nursing, 2021, 28(1): 62-63. |
| [13] | SHI An, JIA Zheng, ZHANG Xuan, ZHANG Su-lan, LIU Zhen-jun, WAN Min. Nursing of Artificial Liver Treatment for Malignant Tumor Patients with Acute Liver Failure after Chemotherapy [J]. Journal of Nursing, 2020, 27(24): 47-49. |
| [14] | TAN Jing, HAN Jiang-quan, HU Chun-ting, LIAN Min-xue, LUO Hong-bo, LI Yan, LIU Ning. Best Evidence Summary for Management of Post-stroke Depression [J]. Journal of Nursing, 2020, 27(23): 42-48. |
| [15] | . [J]. Journal of Nursing, 2020, 27(20): 49-53. |
|